Literature DB >> 16094234

Risk factors for mortality in children with candidemia.

Theoklis E Zaoutis1, Susan E Coffin, Jaclyn H Chu, Kateri Heydon, Huaqing Zhao, H Mollie Greves, Thomas J Walsh.   

Abstract

We performed a retrospective cohort study of hospitalized children with positive blood cultures for Candida species. Independent risk factors for mortality by multivariable analysis were location in the pediatric intensive care unit at the time of infection (hazard ratio, 6.3; 95% confidence interval, 1.6-24.3) and the presence of an arterial catheter (hazard ratio, 2.4; 95% confidence interval, 1.1-5.8). Our findings help identify a group of pediatric patients that should be targeted for future interventions to prevent and treat candidemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16094234     DOI: 10.1097/01.inf.0000172938.76561.8e

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  19 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.

Authors:  Thomas J Walsh; Timothy Driscoll; Peter A Milligan; Nolan D Wood; Haran Schlamm; Andreas H Groll; Hasan Jafri; Antonio C Arrieta; Nigel J Klein; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

3.  Failure to Validate a Multivariable Clinical Prediction Model to Identify Pediatric Intensive Care Unit Patients at High Risk for Candidemia.

Authors:  Brian T Fisher; Rachael K Ross; Emmanuel Roilides; Debra L Palazzi; Mark J Abzug; Jill A Hoffman; David M Berman; Priya A Prasad; A Russell Localio; William J Steinbach; Lambrini Vogiatzi; Ankhi Dutta; Theoklis E Zaoutis
Journal:  J Pediatric Infect Dis Soc       Date:  2015-04-29       Impact factor: 3.164

4.  Risk factors for candidemia in pediatric intensive care unit patients.

Authors:  Hasan Ağın; Ilker Devrim; Rana Işgüder; Utku Karaarslan; Esra Kanık; Ilker Günay; Miray Kışla; Sultan Aydın; Gamze Gülfidan
Journal:  Indian J Pediatr       Date:  2014-03-14       Impact factor: 1.967

5.  Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients.

Authors:  Nita L Seibel; Aziza T Shad; Ihor Bekersky; Andreas H Groll; Corina Gonzalez; Lauren V Wood; Paul Jarosinski; Donald Buell; William W Hope; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

6.  Candida species bloodstream infections in hospitalised children: A 10-year experience.

Authors:  Shannon Chan; Elizabeth D Baley; Jobayer Hossain; M Cecilia Di Pentima
Journal:  J Paediatr Child Health       Date:  2015-05-04       Impact factor: 1.954

7.  Safety and pharmacokinetic profiles of repeated-dose micafungin in children and adolescents treated for invasive candidiasis.

Authors:  Daniel K Benjamin; Jaime G Deville; Nkechi Azie; Laura Kovanda; Mike Roy; Chunzhang Wu; Antonio Arrieta
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

8.  Central Venous Catheter Retention and Mortality in Children With Candidemia: A Retrospective Cohort Analysis.

Authors:  Brian T Fisher; Neika Vendetti; Matthew Bryan; Priya A Prasad; A Russell Localio; Andreas Damianos; Susan E Coffin; Louis M Bell; Thomas J Walsh; Robert Gross; Theoklis E Zaoutis
Journal:  J Pediatric Infect Dis Soc       Date:  2015-08-16       Impact factor: 3.164

9.  Pediatric antifungal utilization: new drugs, new trends.

Authors:  Priya A Prasad; Susan E Coffin; Kateri H Leckerman; Thomas J Walsh; Theoklis E Zaoutis
Journal:  Pediatr Infect Dis J       Date:  2008-12       Impact factor: 2.129

Review 10.  The iC3b receptor of Candida albicans and its roles in pathogenesis.

Authors:  Margaret K Hostetter
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.